ScheBo Biotech AG
ScheBo Biotech AG (ScheBo) is a privately-held biotech company engaged in the design, development and marketing of diagnostic products in-vitro diagnostic products. It develops diagnostic tests for the gastroenterology, oncology, veterinary diagnostic and food and beverage markets. Its gastroenterology diagnostic tests are used for the quantification of human pancreatic elastase1. The company also develops tumor metabolic markers for detecting colorectal cancer and pyruvate kinase antibodies and tests for detecting BSE specified risk material in meat products. It is certified with ISO standards. ScheBo carries out its operations through its subsidiaries, ScheBo Biotech UK Ltd and ScheBo Biotech USA Inc in the UK and the US respectively. ScheBo is headquartered in Giessen, Germany.